» Articles » PMID: 36176910

An Integrative Approach of Digital Image Analysis and Transcriptome Profiling to Explore Potential Predictive Biomarkers for TGF Blockade Therapy

Abstract

Increasing evidence suggests that the presence and spatial localization and distribution pattern of tumor infiltrating lymphocytes (TILs) is associate with response to immunotherapies. Recent studies have identified TGF activity and signaling as a determinant of T cell exclusion in the tumor microenvironment and poor response to PD-1/PD-L1 blockade. Here we coupled the artificial intelligence (AI)-powered digital image analysis and gene expression profiling as an integrative approach to quantify distribution of TILs and characterize the associated TGF pathway activity. Analysis of T cell spatial distribution in the solid tumor biopsies revealed substantial differences in the distribution patterns. The digital image analysis approach achieves 74% concordance with the pathologist assessment for tumor-immune phenotypes. The transcriptomic profiling suggests that the TIL score was negatively correlated with TGF pathway activation, together with elevated TGF signaling activity observed in excluded and desert tumor phenotypes. The present results demonstrate that the automated digital pathology algorithm for quantitative analysis of CD8 immunohistochemistry image can successfully assign the tumor into one of three infiltration phenotypes: immune desert, immune excluded or immune inflamed. The association between "cold" tumor-immune phenotypes and TGF signature further demonstrates their potential as predictive biomarkers to identify appropriate patients that may benefit from TGF blockade.

Citing Articles

Defining Melanoma Immune Biomarkers-Desert, Excluded, and Inflamed Subtypes-Using a Gene Expression Classifier Reflecting Intratumoral Immune Response and Stromal Patterns.

Mlynska A, Gibaviciene J, Kutanovaite O, Senkus L, Mazeikaite J, Kerseviciute I Biomolecules. 2024; 14(2).

PMID: 38397409 PMC: 10886750. DOI: 10.3390/biom14020171.


Activation of insulin-like growth factor-1 receptor (IGF-1R) promotes growth of colorectal cancer through triggering the MEX3A-mediated degradation of RIG-I.

Xie Q, Chu Y, Yuan W, Li Y, Li K, Wu X Acta Pharm Sin B. 2023; 13(7):2963-2975.

PMID: 37521868 PMC: 10372823. DOI: 10.1016/j.apsb.2023.04.001.

References
1.
Mariathasan S, Turley S, Nickles D, Castiglioni A, Yuen K, Wang Y . TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells. Nature. 2018; 554(7693):544-548. PMC: 6028240. DOI: 10.1038/nature25501. View

2.
Kather J, Suarez-Carmona M, Charoentong P, Weis C, Hirsch D, Bankhead P . Topography of cancer-associated immune cells in human solid tumors. Elife. 2018; 7. PMC: 6133554. DOI: 10.7554/eLife.36967. View

3.
Hegde P, Karanikas V, Evers S . The Where, the When, and the How of Immune Monitoring for Cancer Immunotherapies in the Era of Checkpoint Inhibition. Clin Cancer Res. 2016; 22(8):1865-74. DOI: 10.1158/1078-0432.CCR-15-1507. View

4.
Nguyen P, Ma S, Phua C, Kaya N, Lai H, Lim C . Intratumoural immune heterogeneity as a hallmark of tumour evolution and progression in hepatocellular carcinoma. Nat Commun. 2021; 12(1):227. PMC: 7801667. DOI: 10.1038/s41467-020-20171-7. View

5.
Obeid J, Wages N, Hu Y, Deacon D, Slingluff Jr C . Heterogeneity of CD8 tumor-infiltrating lymphocytes in non-small-cell lung cancer: impact on patient prognostic assessments and comparison of quantification by different sampling strategies. Cancer Immunol Immunother. 2016; 66(1):33-43. PMC: 5512540. DOI: 10.1007/s00262-016-1908-4. View